Gotowa bibliografia na temat „Complications oculaires”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Complications oculaires”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Complications oculaires"
Regnier, Alain, Mathilde Goetz i Jean-Yves Douet. "Complications de la chirurgie oculaire chez le cheval". Le Nouveau Praticien Vétérinaire équine 16 (październik 2022): 22–36. http://dx.doi.org/10.1051/npvequi/2023006.
Pełny tekst źródłaGoldstein, Andrei, Julia Hilly i Julie Laboure-Wolf. "Complications oculaires en anesthésie". Le Praticien en Anesthésie Réanimation 10, nr 6 (grudzień 2006): 439–44. http://dx.doi.org/10.1016/s1279-7960(06)75643-1.
Pełny tekst źródłaBarry, A., AI Baldé, AB Kamissoko, M. Ndong Obiang, M. Sanda, K. Condé i M. Touré. "Manifestations oculaires au cours des spondyloarthrites en Guinée". Rhumatologie Africaine Francophone 3, nr 2 (16.10.2022): 6–12. http://dx.doi.org/10.62455/raf.v3i2.34.
Pełny tekst źródłaZamalhèto, Z., L. Legheda, H. Dossou-yovo, M. Gounongbé i I. Sounouvou. "L’œil des patients souffrant de connectivites à Cotonou (Bénin)". Rhumatologie Africaine Francophone 1, nr 2 (31.08.2021): 17–22. http://dx.doi.org/10.62455/raf.v1i2.6.
Pełny tekst źródłaMartenet, A. C. "Complications oculaires du SIDA - Problèmes diagnostiques". Klinische Monatsblätter für Augenheilkunde 200, nr 05 (maj 1992): 555–58. http://dx.doi.org/10.1055/s-2008-1045826.
Pełny tekst źródłaNghe, Marie-Claire. "Complications oculaires en chirurgie non ophtalmologique". Le Praticien en Anesthésie Réanimation 22, nr 4 (wrzesień 2018): 195–202. http://dx.doi.org/10.1016/j.pratan.2018.06.008.
Pełny tekst źródłaHéron, E., I. Rossignol, A. Chibani, F. Mihoubi-Mantout, M. Baudrimont, M. Sterkers i S. Feldman-Billard. "Complications oculaires de la maladie de Horton". La Revue de Médecine Interne 28 (czerwiec 2007): 57. http://dx.doi.org/10.1016/j.revmed.2007.03.077.
Pełny tekst źródłaMAZARI, Fettouma. "The place of eye exam in the follow-up of the arterial hypertension". Batna Journal of Medical Sciences (BJMS) 6, nr 1 (1.07.2019): 77–81. http://dx.doi.org/10.48087/bjmscr.2019.6124.
Pełny tekst źródłaMathis, T., V. Fortoul, L. Kodjikian i P. Denis. "Complications oculaires de l’implant esthétique coloré NewColorIris®". Journal Français d'Ophtalmologie 38, nr 6 (czerwiec 2015): e107-e109. http://dx.doi.org/10.1016/j.jfo.2014.12.004.
Pełny tekst źródłaEz-zahraoui, M. R., M. Y. El Bakkouri, I. Hajji i A. Moutaouakil. "Complications oculaires secondaires au traitement d’un ptérygion par apipuncture". Journal Français d'Ophtalmologie 40, nr 5 (maj 2017): 447–49. http://dx.doi.org/10.1016/j.jfo.2016.11.020.
Pełny tekst źródłaRozprawy doktorskie na temat "Complications oculaires"
Mercié, Martial. "Syndromes paranéoplasiques oculaires". Bordeaux 2, 1997. http://www.theses.fr/1997BOR23016.
Pełny tekst źródłaBAKRI, MOTASSEM. "Les complications oculaires des angiomes immatures de la paupiere : a propos de 11 observations". Lyon 1, 1989. http://www.theses.fr/1989LYO1M293.
Pełny tekst źródłaPokitonoff, Mathilde Catherine Sophie. "Contribution à l'étude des complications oculaires de l'influenza Thèse pour le doctorat en médecine présentée et soutenue le jeudi 24 juillet 1890 /". Paris : BIUM, 2003. http://www.bium.univ-paris5.fr/histmed/medica/cote?TPAR1890x362.
Pełny tekst źródłaCassagne, Myriam. "Etude physiopathologique des complications oculaires observées chez des patients atteints de dermatite atopique traitée par Dupilumab". Electronic Thesis or Diss., Toulouse 3, 2023. http://www.theses.fr/2023TOU30288.
Pełny tekst źródłaDupilumab has proven its efficacy in the treatment of moderate to severe atopic dermatitis (AD). However, the occurrence of ocular adverse events (OAEs) has been reported. The objectives of this work were to describe the incidence and nature of OAEs induced by dupilumab in AD patients, to evaluate potential predisposing factors, and to understand their molecular bases. We conducted a first single-center, prospective, real-life study in adult AD patients treated with dupilumab, who were systematically examined by an ophthalmologist before and during treatment. We included 46 patients with a median initial SCORing of AD (SCORAD) of 46.0 (interquartile range: 34.5-55.5). 34.8% of patients experienced OAEs, often mild to moderate, but leading to interruption of dupilumab for two patients. The majority of patients developed or worsened dry eye. Six patients (13%) developed conjunctivitis de novo. Dupilumab-induced OAEs were associated with dry eye with superficial punctuate keratitis (Odds ratio (OR) = 6.3 95% confidence interval (CI): [1.3-31.6]), eyelid eczema (OR= 8.7; 95% CI: [1.8-40.6]), a history of food allergy (OR = 3.8; 95% CI: [1.002-14.070]) and/or serum IgE levels > 1.000 kU/L (OR = 10.6; 95% CI: [1.2-91.3]). We then participated to a national multicenter study which included 181 patients. Thirty-four patients (18.7%) presented blepharoconjunctivitis induced by dupilumab: either de novo (n=32; 17.6%) or by worsening of a pre-existing condition (n=2; 1.1%). Most events (27/34; 79.4%) were moderate. Multivariate analysis showed that AD with head and neck involvement (OR = 7.254; 95% CI [1.938-30.07]; p = 0.004), erythroderma (OR = 5.635; 95% CI [1.635] -21.50]; p = 0.007) and the presence of dry eye syndrome before treatment (OR = 3.51; 95% CI [3.158-13.90]; p = 0.031) were independent factors associated with dupilumab-induced blepharoconjunctivitis. The SCORAD or the response to treatment (% improvement in SCORAD at W16), a history of allergic conjunctivitis, asthma or rhinitis were also not significantly associated with the occurrence of OAE. Finally, we conducted a bicentric study, comparing the transcriptome (analyzed by DNA microarrays and RT-qPCR) and the expression of the chemokine CCL20 (by ELISA) of conjunctival cells, collected by conjunctival impression, on AD patients before (M0) and 4 months after dupilumab beginning (M4). Thirty-six patients were included and divided in two groups, according their ophthalmological status at M4: one group of 12 who developed OAE (OAE+) and another group of 24 who did not (OAE-). In multiple analysis of the full transcriptome, we found 52 differentially expressed genes (DEG) between OAE+/M0 and OAE-/M0, 113 DEG between OAE+/M4 and OAE-/M4, two DEG between OAE+/M0 and OAE+/M4, and none DEG between OAE-/M0 and OAE-/M4. Ingenuity Pathway Analysis enrichment with a special interest in diseases, mainly indicated a psoriasis signature. Among the 15 DEG selected for RT-qPCR validation, only 7 were significant: CCL20, IL-19, NOX1, NOS2, SLC26A4 and S100A12 were up-regulated, whereas MUC-7 was downregulated in OAE+/M4 vs OAE-/M4 patients. CCL20 protein quantification by ELISA confirmed an over-expression between M0 and M4 for the two groups. In conclusion, most cases of dupilumab-induced blepharoconjunctivitis are de novo. Pre-existing factors (dry eye syndrome, AD with eyelid, head and neck) are associated with an increased risk of OAE. Dupilumab seems to switch AD immunological profile of OAE patients from Th2 to Th17, particularly involved in psoriasis
Lellouche, Eric. "L'immunité locale dans deux parasitoses oculaires, toxoplasmose et onchocércose". Paris 5, 1993. http://www.theses.fr/1993PA05P084.
Pełny tekst źródłaGaboriaud, Corinne. "Manifestations ophtalmologiques des vascularites : à propos de deux cas". Bordeaux 2, 1992. http://www.theses.fr/1992BOR2M076.
Pełny tekst źródłaJAIME, SONIA. "Complications immediates et secondaires des plaies penetrantes du segment anterieur (limbe inclus, corps etrangers intra-oculaires inclus, sequelles eloignees exclues)". Lyon 1, 1988. http://www.theses.fr/1988LYO1M213.
Pełny tekst źródłaBelso, Laurence. "Syndrome de Terson : étude rétrospective à propos de quatre cas". Montpellier 1, 1997. http://www.theses.fr/1997MON11163.
Pełny tekst źródłaGodenèche, Benoît. "Glaucome évolutif à pression intra-oculaire normalisée. Etude à partir de l'enregistrement sur le nycthémère de la tension oculaire couplé à la tension artérielle". Bordeaux 2, 1997. http://www.theses.fr/1997BOR23078.
Pełny tekst źródłaPLOEGAERTS, PHILIPPE. "Segment posterieur et radiations ionisantes : a propos de 36 cas de tumeur intra-oculaire traites par radiotherapie". Lille 2, 1991. http://www.theses.fr/1991LIL2M016.
Pełny tekst źródłaKsiążki na temat "Complications oculaires"
1934-, Fraunfelder Frederick T., Roy Frederick Hampton i Meyer S. Martha, red. Current ocular therapy 3. Philadelphia: Saunders, 1990.
Znajdź pełny tekst źródłaOphthalmology, American Academy of. Lens and cataract, 2007-2008. Wyd. 2. [San Francisco]: American Academy of Ophthalmology, 2007.
Znajdź pełny tekst źródłaTakao, Kumazawa, Kruger Lawrence i Mizumura Kazue, red. The polymodal receptor: A gateway to pathological pain. Amsterdam: Elsevier, 1996.
Znajdź pełny tekst źródłaFrauenfelder i Roy. Current Ocular Therapy, Book 3. W.B. Saunders Company, 1989.
Znajdź pełny tekst źródła(Editor), T. Kumazawa, L. Kruger (Editor) i K. Mizumura (Editor), red. The Polymodal Receptor - A Gateway to Pathological Pain (Progress in Brain Research). Elsevier Science, 1996.
Znajdź pełny tekst źródłaStreszczenia konferencji na temat "Complications oculaires"
Landric, C., C. Alande i M. Ndiaye. "Apport de la greffe gingivale épithélio conjonctive dans la reconstruction palpébrale". W 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206602014.
Pełny tekst źródła